scispace - formally typeset
Open AccessJournal Article

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

Reads0
Chats0
TLDR
Since intensive glucose control with metformin appears to decrease the risk of diabetes-related endpoints in overweight diabetic patients, and is associated with less weight gain and fewer hypoglycaemic attacks than are insulin and sulphonylureas, it may be the first-line pharmacological therapy of choice in these patients.
About
This article is published in The Lancet.The article was published on 1998-09-12 and is currently open access. It has received 7395 citations till now. The article focuses on the topics: Metformin & Type 2 diabetes.

read more

Citations
More filters
Journal ArticleDOI

Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.

TL;DR: The data suggest that metformin treatment is effective in reducing insulin resistance and also ameliorating metabolic complications of insulin resistance syndrome in obese adolescents with hyperinsulinemia.
Journal ArticleDOI

Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study

TL;DR: In this article, ethnicity-specific BMI cutoffs for obesity based on the risk of type 2 diabetes that are risk-equivalent to the BMI cutoff for obesity among white populations (≥30 kg/m2) were identified by using a CALIBER phenotyping algorithm.
Journal ArticleDOI

Screening for type 2 diabetes: a short report for the National Screening Committee

TL;DR: The case for screening for type 2 diabetes mellitus is less strong than it was in the 2007 review, mainly due to the absence of cardiovascular benefit in the two trials published since the previous review.
Journal ArticleDOI

Insulin resistance – a common link between type 2 diabetes and cardiovascular disease

TL;DR: The development of agents with both PPARα and PPARγ activity promises added benefits with amelioration of insulin resistance, delayed progression to and of type 2 diabetes and a reduction of CVD.
Journal ArticleDOI

Forecasting the Future Economic Burden of Current Adolescent Overweight: An Estimate of the Coronary Heart Disease Policy Model

TL;DR: Current adolescent overweight will likely lead to large future economic and health burdens, especially lost productivity from premature death and disability, and application of currently available medical treatments will not greatly reduce these future burdens of increased adult obesity.
References
More filters
Journal Article

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 - 
TL;DR: In this article, the effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial were compared.
Journal Article

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease

TL;DR: Sulfonylurea, metformin, and insulin therapies were similarly effective in improving glucose control compared with a policy of diet therapy and whether any specific therapy is advantageous or disadvantageous.
Journal ArticleDOI

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

TL;DR: The ability of troglitazone to reduce insulin resistance and improves glucose tolerance in obese subjects with either impaired or normal glucose tolerance could be useful in preventing NIDDM.
Journal ArticleDOI

Biguanides and NIDDM

TL;DR: Because metformin does not cause clinical hypoglycemia, it is actually an antihyperglycemic drug that helps combat hypertriglyceridemia, and it has been ascribed some vasoprotective properties.
Journal ArticleDOI

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

TL;DR: The UK Prospective Diabetes Study is a multi-centre, prospective, randomised, intervention trial of 5100 newly-diagnosed patients with Type 2 (non-insulin-dependent) diabetes mellitus which aims to determine whether improved blood glucose control will prevent complications and reduce the associated morbidity and mortality.
Related Papers (5)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 -